Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-24-031113

Options or other derivatives

  • Interim CEO & General Counsel acquired 593,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Vogt Frederick G · Interim CEO & General Counsel

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-03-01 Grant or award : show line 1 in the form Restricted Stock Units +500,000 500,000 D
2024-03-01 Grant or award : show line 2 in the form Restricted Stock Units +93,750 93,750 D
Loading xslF345X05/tm248017-9_4seq1.xml…